GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
V

Vicore Pharma Holding VICO.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

10.82

+5.87%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in SEK, from our data supplier.

FY2024

Revenue

SEK 109.3m

FY2015FY2024

Net income

−SEK 168.6m

FY2015FY2024

Free cash flow

−SEK 164.9m

FY2015FY2024

Shareholders' equity

SEK 1.13bn

FY2015FY2024

Income statement

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
RevenueSEK 109.3m—————SEK 508,000SEK 932,000SEK 852,000SEK 840,000
Gross profit—————————SEK 1.7m
Research and developmentSEK 247.0mSEK 276.3mSEK 250.0mSEK 271.8mSEK 142.0mSEK 67.0mSEK 20.5mSEK 17.6mSEK 12.3m—
Operating income−SEK 190.4m−SEK 259.0m−SEK 290.7m−SEK 294.8m−SEK 149.5m−SEK 94.0m−SEK 41.6m−SEK 28.2m−SEK 20.1m−SEK 4.5m
Net income−SEK 168.6m−SEK 310.9m−SEK 288.4m−SEK 296.5m−SEK 146.9m−SEK 93.1m−SEK 21.7m−SEK 24.2m−SEK 24.5m−SEK 4.6m
Diluted earnings per share-1.23-3.13-3.89-4.14-2.71-2.16-0.95-1.25-1.55-0.32

Balance sheet

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Total assetsSEK 1.20bnSEK 497.8mSEK 338.0mSEK 451.2mSEK 406.5mSEK 341.1mSEK 301.6mSEK 64.1mSEK 37.6mSEK 89.2m
Cash and short-term investmentsSEK 1.16bnSEK 482.7mSEK 261.7mSEK 371.5mSEK 318.7mSEK 264.6mSEK 224.7mSEK 24.0mSEK 4.3mSEK 25.2m
Total liabilitiesSEK 73.8mSEK 42.4mSEK 48.9mSEK 67.9mSEK 52.0mSEK 19.5mSEK 16.2mSEK 6.6mSEK 6.1mSEK 7.3m
Debt——SEK 65,000SEK 320,000SEK 140,000SEK 190,000————
Shareholders' equitySEK 1.13bnSEK 455.4mSEK 289.1mSEK 383.3mSEK 354.5mSEK 321.6mSEK 285.4mSEK 57.6mSEK 31.6mSEK 81.9m
Shares outstanding137m99m74m72m54m43m23m19m16m14m

Cash flow

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Cash from operations−SEK 164.9m−SEK 249.6m−SEK 299.9m−SEK 265.2m−SEK 119.9m−SEK 87.0m−SEK 33.0m−SEK 27.9m−SEK 20.7m−SEK 3.7m
Capital spending——−SEK 3.0m—−SEK 3.0m−SEK 147,000−SEK 2.0m−SEK 33,000—−SEK 5.7m
Free cash flow−SEK 164.9m−SEK 249.6m−SEK 302.9m−SEK 265.2m−SEK 122.9m−SEK 87.1m−SEK 35.0m−SEK 27.9m−SEK 20.7m−SEK 9.3m

Latest quarters

By quarter end

Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023
RevenueSEK 760,000SEK 1.7mSEK 892,000SEK 5.1m——SEK 104.2m—
Operating income−SEK 116.0m−SEK 111.2m−SEK 91.5m−SEK 94.1m−SEK 60.1m−SEK 63.1mSEK 23.2m−SEK 70.1m
Net income−SEK 113.5m−SEK 115.4m−SEK 111.5m−SEK 84.1m−SEK 59.9m−SEK 56.3mSEK 31.7m−SEK 111.9m
Diluted earnings per share-0.48-0.49-0.48-0.40-0.54-0.490.28-0.97
Total assetsSEK 866.7mSEK 976.5mSEK 1.08bnSEK 1.20bnSEK 406.9mSEK 478.7mSEK 540.7mSEK 497.8m
Cash and short-term investmentsSEK 835.8mSEK 937.0mSEK 1.05bnSEK 1.16bnSEK 380.4mSEK 466.4mSEK 512.2mSEK 482.8m
Shareholders' equitySEK 798.7mSEK 908.3mSEK 1.02bnSEK 1.13bnSEK 377.7mSEK 435.0mSEK 488.8mSEK 455.4m

Financial ratios

Data as of 24 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Gross margin100.0%100.0%—————-4182.7%383.8%243.3%197.1%—
Operating margin-12507.6%-154.4%—————-7530.3%-2555.9%-780.8%-540.8%—
Net margin-12509.1%-154.2%—————-4267.9%-1379.3%-780.8%-544.0%—
Return on equity-43.6%-14.9%-68.3%-99.8%-77.3%-41.4%——————
Return on assets-39.1%-14.0%-62.5%-85.3%-65.7%-36.1%——————
Free cash flow yield0.0%-4.9%-4.8%-42.4%—-22.1%-21.5%—————
Revenue growth-96.5%——————-45.5%9.4%1.4%-46.5%-52.5%
Earnings growth183.1%-45.8%7.8%-2.7%101.9%57.8%——————
Current ratio10.31x16.50x12.10x5.81x5.75x6.82x——————
Debt to equity0.00x0.00x0.00x0.00x0.00x0.00x——————
Equity ratio89.8%93.9%91.5%85.5%85.0%87.2%——————
Interest coverage-9.48x-21110.25x-896.34x-36226.63x-26674.55x-24551.50x——————
R&D as a share of sales10226.6%228.0%—————4028.1%1883.6%1438.6%460.5%—
Buybacks as a share of market value-18.4%-93.4%-52.0%8.7%-44.6%-31.4%——————

Growth per year

Compound annual rate

3 years5 years10 years
Revenue——62.5%
Operating income-13.6%15.2%42.8%
Net income-17.1%12.6%—

Valuation history

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Price to earnings-6.9-2.3-2.3-1.7-5.9-3.5-8.6-6.8-6.3-10.1
Price to sales10.6—————365.9175.9181.455.0

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.